Report

Global Breast Cancer Therapeutics Market Size study, By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, e-commerce, Retail Pharmacies), and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Breast Cancer Therapeutics Market, by Region, 2018-2027 (USD Billion)
1.2.2. Breast Cancer Therapeutics Market, by Product, 2018-2027 (USD Billion)
1.2.3. Breast Cancer Therapeutics Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Cancer Therapeutics Market Definition & Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Cancer Therapeutics Market Dynamics
3.1. Breast Cancer Therapeutics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Breast Cancer Therapeutics Market: Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Breast Cancer Therapeutics Market, by Product
5.1. Market Snapshot
5.2. Global Breast Cancer Therapeutics Market by Product, Performance - Potential Analysis
5.3. Global Breast Cancer Therapeutics Market Estimates & Forecasts by Product, 2017-2027 (USD Billion)
5.4. Breast Cancer Therapeutics Market, Sub Segment Analysis
5.4.1. Hormone Drugs
5.4.2. Chemotherapy Drugs
5.4.3. Targeted Drug Therapy
Chapter 6. Global Breast Cancer Therapeutics Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Breast Cancer Therapeutics Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Breast Cancer Therapeutics Market Estimates & Forecasts by Distribution Channel, 2017-2027 (USD Billion)
6.4. Breast Cancer Therapeutics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Ambulatory Surgical Centres
6.4.3. Clinics
6.4.4. e-commerce
6.4.5. Retail Pharmacies
Chapter 7. Global Breast Cancer Therapeutics Market, Regional Analysis
7.1. Breast Cancer Therapeutics Market, Regional Market Snapshot
7.2. North America Breast Cancer Therapeutics Market
7.2.1. U.S. Breast Cancer Therapeutics Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Breast Cancer Therapeutics Market
7.3. Europe Breast Cancer Therapeutics Market Snapshot
7.3.1. U.K. Breast Cancer Therapeutics Market
7.3.2. Germany Breast Cancer Therapeutics Market
7.3.3. France Breast Cancer Therapeutics Market
7.3.4. Spain Breast Cancer Therapeutics Market
7.3.5. Italy Breast Cancer Therapeutics Market
7.3.6. Rest of Europe Breast Cancer Therapeutics Market
7.4. Asia-Pacific Breast Cancer Therapeutics Market Snapshot
7.4.1. China Breast Cancer Therapeutics Market
7.4.2. India Breast Cancer Therapeutics Market
7.4.3. Japan Breast Cancer Therapeutics Market
7.4.4. Australia Breast Cancer Therapeutics Market
7.4.5. South Korea Breast Cancer Therapeutics Market
7.4.6. Rest of Asia Pacific Breast Cancer Therapeutics Market
7.5. Latin America Breast Cancer Therapeutics Market Snapshot
7.5.1. Brazil Breast Cancer Therapeutics Market
7.5.2. Mexico Breast Cancer Therapeutics Market
7.6. Rest of The World Breast Cancer Therapeutics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. AstraZeneca
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Industry Summary
8.2.1.5. Recent Developments
8.2.2. Bristol-Myers Squibb
8.2.3. Eisai Co. Ltd
8.2.4. Eli Lilly and Company
8.2.5. Genentech
8.2.6. GlaxoSmithKline
8.2.7. Halozyme Inc.
8.2.8. Novartis AG
8.2.9. Pfizer Inc.
8.2.10. Genzyme Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption